M
Meacor
Developing novel minimally invasive medical devices
About Meacor
Meacor is a medical device company that specializes in the development of minimally invasive solutions for heart valve repair. The company is focused on creating transcatheter interventions for valvular disease, with its flagship technology being the CryoCinch system.
Recently, Meacor has secured a significant capital infusion of $15 million through a Series A funding round. This financing is intended to advance the development and commercialization of its heart valve repair technology. The company serves the medical community, specifically targeting cardiologists and surgeons who perform heart valve procedures. Its business model revolves around the research, development, and subsequent sale of its proprietary medical devices to hospitals and clinics. The primary market is the cardiovascular device sector, a field with a continuous demand for less invasive treatment options.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Irvine, United States
- Employees
- 8
- Open positions
- 1
- Dealroom signal
- 82.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, medical implants, Surgery, Cardiology and cardiovascular, Valves, Spinout, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2024 | $15M | $60M | Undisclosed | ↗ |
| OtherOther financing | Jun 2022 | $0 | — | MedTech Innovator | ↗ |
Growth signals
Latest recorded traffic for Meacor is 440 monthly website visits, down 79% over the last three months. Meacor's team grew 100% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Im Capital
Kafalat
Other known investors4 additional known investors
McGill University
MedTech Innovator
McGill Dobson Centre for Entrepreneurship
Middle East Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Meacor on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Meacor’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.